Skip to main content
. 2020 Jan 1;11(6):1299–1307. doi: 10.7150/jca.34423

Figure 7.

Figure 7

Schematic representation of the p62- Keap1- Nrf2 pathway in ovarian cancer cells with the treatment of VK3. Our study provides evidence that p62 promotes Nrf2 signaling through interacting with Keap1, which blocks VK3-induced apoptosis by inhibiting ROS production in SKOV3/DDP cells.